| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8445899 | European Journal of Cancer | 2012 | 9 Pages |
Abstract
In conclusion, our results show without ambiguity that in South European populations, MC1R RHC and SCL45A2 p.Phe374Leu variants are strong melanoma risk predictors, notably in those individuals who would not be identified as high risk based on their phenotypes or exposures alone. The use of these biomarkers in clinical practice could be promising and warrants further discussion.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Maider Ibarrola-Villava, Hui-Han Hu, Mickaël Guedj, Lara P. Fernandez, Vincent Descamps, Nicole Basset-Seguin, Martine Bagot, Armand Benssussan, Philippe Saiag, Maria Concetta Fargnoli, Ketty Peris, Jose A. Aviles, Ana Lluch, Gloria Ribas, Nadem Soufir,